Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-20 Purchase | 2023-03-22 4:03 pm | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,000 | $2.484 | $49,680 | 23,472 (Direct) | View |
| 2023-03-20 Purchase | 2023-03-22 4:01 pm | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 10,000 | $2.5 | $25,000 | 22,721 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-30 Tax Withholding | 2023-07-05 4:37 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 91 | $4.1 | 8,017 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:34 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 151 | $4.1 | 10,239 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 157 | $4.1 | 25,750 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:30 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 981 | $4.1 | 52,433 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:34 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,664 | $3.4563 | 25,907 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:31 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 2,766 | $3.4563 | 53,414 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:07 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 384 | $3.08 | 8,108 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 480 | $3.08 | 10,390 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:03 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 478 | $3.08 | 22,243 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 2,734 | $3.08 | 50,648 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.15 | 229,144 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,720 | $0.15 | 220,252 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 354 | $0.15 | 173,005 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:03 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 10,685 | $0.15 | 1,064,290 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:30 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 34,705 | $0.1977 | 1,074,975 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 353 | $0.223 | 173,359 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,719 | $0.223 | 221,972 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:04 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.223 | 230,957 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 10,683 | $0.223 | 1,040,270 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:12 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:11 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:11 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:10 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:10 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 354 | $0.389 | 173,712 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,719 | $0.389 | 223,691 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,813 | $0.389 | 232,770 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:00 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 10,683 | $0.389 | 1,050,953 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 12,510 | $0.3463 | 174,066 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:35 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 11,887 | $0.3463 | 1,061,636 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:10 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 773 | $0.65 | 161,556 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 3,469 | $0.65 | 225,410 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 3,630 | $0.65 | 234,583 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 23,186 | $0.65 | 1,049,749 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 75,000 | $0 | 237,329 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 75,000 | $0 | 303,879 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:09 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 75,000 | $0 | 313,213 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:09 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 624,605 | $0 | 1,385,238 (Direct) | View |